Clinical TrialsSearch results
Number of results: 701
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Recruiting
- A Study of TAK-341 in Treatment of Multiple System Atrophy
- Multiple System Atrophy
- Nonomura Hidenori
- 2022-12-20
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- [M22-984] A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused ABBV-383 of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
- Multiple Myeloma
- Satomi Natsuko
- 2022-03-26
Other
- Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation
- Multiple Myeloma
- Myeloma Bone Disease Study Group
- 2008-10-17
Other
- Cytogenetic features and its clinical implications in Japanese patients with multiple myeloma: retrospective analysis by Japan Myeloma Study Group
- multiple myeloma
- Japan Myeloma Study Group
- 2008-09-22
Not yet recruiting
- Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients
- Multiple Myeloma
- Division of clinial oncology and hematology, Jikei University School of Medicine
- 2009-07-06
Recruiting
- A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA versus VRd followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants with Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
- Multiple Myeloma
- Fujikawa Ei
- 2021-07-30
Recruiting
- PHE885 CAR-T therapy in adult participants with relapsed and refractory multiple myeloma
- Multiple myeloma
- Hirano Takamitsu
- 2022-07-25